G1 THERAPEUTICS INC. - COMMON STOCK

G1 Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 1, 2023

18 10 2023 06:30:06 提供 Nasdaq GlobeNewswire

G1 Therapeutics Announces Upcoming Presentations at the 2023 ASCO Quality Care Symposium

16 10 2023 08:00:33 提供 Nasdaq GlobeNewswire

G1 Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

05 9 2023 10:00:29 提供 Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 9 2023 15:15:21 提供 Nasdaq GlobeNewswire

G1 Therapeutics Provides Second Quarter 2023 Financial Results and Operational Highlights

02 8 2023 05:30:27 提供 Nasdaq GlobeNewswire

G1 Therapeutics to Participate in Two August Investor Conferences

31 7 2023 13:30:27 提供 Nasdaq GlobeNewswire

New Publication Highlights Real World Impact of Trilaciclib on Myelosuppressive Events in Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC)

31 7 2023 07:30:40 提供 Nasdaq GlobeNewswire

G1 Therapeutics to Release Second Quarter 2023 Financial Results and Provide Business Update on August 2, 2023

26 7 2023 08:00:31 提供 Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 7 2023 15:15:03 提供 Nasdaq GlobeNewswire

Trilaciclib Increases Pool of Memory T Cells in the Tumor Microenvironment Responsible for Long Term Immune Surveillance and Efficacy

04 6 2023 06:13:44 提供 Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 6 2023 15:40:59 提供 Nasdaq GlobeNewswire

G1 Therapeutics Announces Appointment of Monica Thomas as General Counsel

22 5 2023 15:45:22 提供 Nasdaq GlobeNewswire

New Study Confirms Consistent Risk of Myelosuppression Across All Patients Receiving Chemotherapy for Small Cell Lung Cancer

16 5 2023 06:30:11 提供 Nasdaq GlobeNewswire

New Results from Phase 2 Trial Confirm Benefit of Trilaciclib in Reducing Adverse Events Related to an Antibody Drug Conjugate (ADC)

10 5 2023 06:31:04 提供 Nasdaq GlobeNewswire

G1 Therapeutics Provides First Quarter 2023 Financial Results and Operational Highlights

03 5 2023 05:30:55 提供 Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 5 2023 16:00:50 提供 Nasdaq GlobeNewswire

G1 Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 3, 2023

26 4 2023 11:45:27 提供 Nasdaq GlobeNewswire

G1 Therapeutics to Participate in the 22nd Annual Needham Virtual Healthcare Conference

11 4 2023 11:30:49 提供 Nasdaq GlobeNewswire

G1 Therapeutics Provides Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights

01 3 2023 05:30:27 提供 Nasdaq GlobeNewswire

G1 Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference

28 2 2023 13:10:49 提供 Nasdaq GlobeNewswire